Trial site
Taipei
- 7running trials
- 7closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)4 trials
- COPD3 trials
- Asthma2 trials
- Haemophilia2 trials
- Bronchiectasis1 trial
- Cystic fibrosis1 trial
- Fabry disease1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 38 trials
- Phase 24 trials
- Phase 2/31 trial
- Status
- Completed6 trials
- Active, not recruiting5 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Sanofi13 trials
- Genzyme, a Sanofi Company1 trial
Running trials
Recruiting
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Completed
Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in Taiwan
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026